AAAAAA
Results: 26-30/30
Authors:
FAGERBERG J
STOCKELD D
LEWENSOHN R
Citation: J. Fagerberg et al., COMBINED TREATMENT MODALITIES IN ESOPHAGEAL CANCER - SHOULD CHEMOTHERAPY BE INCLUDED, Acta oncologica, 33(4), 1994, pp. 439-450
Authors:
SHETYE J
MATHIESEN T
FAGERBERG J
RUBIO C
Citation: J. Shetye et al., EAR TUMORS INDUCED BY EXPERIMENTAL CARCINOGENESIS IN THE RAT - EXCISION PREVENTS EARLY DEATH, International journal of colorectal disease, 9(3), 1994, pp. 125-127
Authors:
FAGERBERG J
Citation: J. Fagerberg, TECHNOLOGY AND INTERNATIONAL DIFFERENCES IN GROWTH-RATES, Journal of economic literature, 32(3), 1994, pp. 1147-1175
Authors:
WERSALL JP
MASUCCI G
HJELM AL
RAGNHAMMAR P
FAGERBERG J
FRODIN JE
MERK K
LINDEMALM C
ERICSON K
KALIN B
MELLSTEDT H
Citation: Jp. Wersall et al., LOW-DOSE CYCLOPHOSPHAMIDE, ALPHA-INTERFERON AND CONTINUOUS INFUSIONS OF INTERLEUKIN-2 IN ADVANCED RENAL-CELL CARCINOMA, Medical oncology and tumor pharmacotherapy, 10(3), 1993, pp. 103-111
Authors:
FAGERBERG J
FRODIN JE
WIGZELL H
MELLSTEDT H
Citation: J. Fagerberg et al., INDUCTION OF AN IMMUNE NETWORK CASCADE IN CANCER-PATIENTS TREATED WITH MONOCLONAL-ANTIBODIES (AB(1)) .1. MAY INDUCTION OF AB(1)-REACTIVE T-CELLS AND ANTI-ANTI-IDIOTYPIC ANTIBODIES (AB(3)) LEAD TO TUMOR-REGRESSION AFTER MAB THERAPY, Cancer immunology and immunotherapy, 37(4), 1993, pp. 264-270